REVBW Earnings REVELATION BIOSCIENCES, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -2.71 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -23.95 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -9.76 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -13.60 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -25.34 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -1052.16 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -354.05 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -390.02 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -39.37 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -8.44 | 2025-03-06 | 10-K |
| Q3 2024 | 2023-09-30 | 9.38 | 2024-11-08 | 10-Q |
| Q2 2024 | 2023-06-30 | 23.89 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | 37.07 | 2024-05-10 | 10-Q |
| FY 2023 | 2022-12-31 | -149.20 | 2024-03-22 | 10-K |
| Q3 2023 | 2022-09-30 | -19.61 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -19.71 | 2023-08-11 | 10-Q |
| Q1 2023 | 2022-03-31 | -15.90 | 2023-05-22 | 10-Q |
| FY 2022 | 2021-12-31 | -42.50 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -3.83 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.61 | 2022-08-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.